insights_auto
Why is BOT down 9.09%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.010
arrow_downward
-9.09%(-0.0010) 1D
Nov 6, 4:10:28 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
30.39M
Avg. vol.
9.20M
Volume
23.69M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
30.39M
Avg. vol.
9.20M
Volume
23.69M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
RealMoney Pro
·
1 hour ago
Tech Bounces, but the S&P 500 Still Has Its Worst Week Since April 2025
inkl
·
35 minutes ago
Nasdaq, S&P 500, Russell 2000 jump, Dow Jones down at US Stock Market, check top performing Wall Street stocks
www.tokenpost.com
·
51 minutes ago
Nasdaq Composite Falls More Than 10% From Oct. 6 Closing High
www.tmgm.com
·
3 hours ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com